- Home
- / American Renal Associates
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
American Renal Associates financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$822.5 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|
| Revenue | 805.8M | 822.5M | ||
| General and administrative expense | 127.6M | 102.6M | 101.1M | 91.1M |
| Operating expense total | 127.6M | 102.6M | 101.1M | 91.1M |
| Depreciation and amortization | 33.9M | 37.6M | 39.8M | 43.8M |
| EBIT | 126.8M | 106.5M | 55.3M | 51.7M |
| EBIT margin, % | 6.9% | 6.3% | ||
| Interest expense | 35.9M | 29.3M | 32.6M | |
| Pre tax profit | 87.5M | 83.9M | 25.4M | 8.3M |
| Income tax expense | (753.0K) | 8.2M | 2.9M | (17.8M) |
| Net Income | (385.0K) | 4.9M | (28.8M) | 26.1M |